Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Continuous vs Intermittent Ampicillin and Ceftriaxone for E. faecalis Endocarditis
NCT06423898Phase 4Recruiting
- Sponsor
- Fundación Pública Andaluza para la Gestión de la Investigación
- Start
- Oct 2024
- Primary completion
- Jul 2027
- Modality
- Reversible Covalent Inhibitors
- Countries
- 1
01
Overview
A Phase 4 trial of ampicillin, ceftriaxone in infective endocarditis (IE), sponsored by Fundación Pública Andaluza para la Gestión de la Investigación. Started Oct 2024; status: recruiting.
02
Drugs
ampicillinceftriaxone
03
Conditions
infective endocarditis (IE)
Beyond the preview
Go deeper on NCT06423898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06423898.